Literature DB >> 14967550

Effects of hyperventilation on heart rate and QT variability in panic disorder pre- and post-treatment.

Gregory M Sullivan1, Justine M Kent, Marc Kleber, Jose M Martinez, Vikram K Yeragani, Jack M Gorman.   

Abstract

Panic disorder is associated with an elevated risk of cardiovascular disease and sudden death. Individuals with panic disorder have been shown to have reduced variability in heart rate and increased variability in the QT interval on electrocardiogram (ECG), patterns predictive of sudden cardiac death in certain forms of cardiomyopathy. Given that panic disorder patients often hyperventilate during a panic attack, we assessed the effects of voluntary hyperventilation on the ECG utilizing linear analyses of heart rate and QT interval variability. Sixteen symptomatic, medication-free patients underwent hyperventilation challenge. A small subgroup of eight subjects underwent re-challenge after treatment. Pre-treatment, hyperventilation resulted in a decrease in a measure of heart rate variability and an increase in the QT variability index (QTVI; QT variance normalized for mean QT, divided by heart rate variance normalized for mean heart rate). In a remitted state, the QTVI was reduced both during rest and during hyperventilation compared with the respective pre-treatment levels. These findings suggest a possible mechanism explaining increased rates of cardiovascular morbidity and mortality in panic disorder. Moreover, the reduction in QTVI observed post-treatment raises the question of whether treatment might have cardioprotective effects, at least in panic disorder patients who have particular types of co-morbid cardiac disease. Yet these results must be interpreted cautiously; they are preliminary, exploratory and observed in a very small sample without a healthy comparison group.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14967550     DOI: 10.1016/j.psychres.2003.10.002

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  6 in total

Review 1.  Anxiety and Cardiovascular Disease Risk: a Review.

Authors:  Phillip J Tully; Nathan J Harrison; Peter Cheung; Suzanne Cosh
Journal:  Curr Cardiol Rep       Date:  2016-12       Impact factor: 2.931

2.  Evidence for cardiotoxicity associated with sertraline in rats.

Authors:  Sinem Ilgin; Volkan Kilic; Merve Baysal; Gozde Aydogan-Kilic; Seyda Ucarcan; Begum Dermenci; Ozlem Atli
Journal:  Toxicol Res (Camb)       Date:  2018-04-06       Impact factor: 3.524

Review 3.  Anxiety and medical disorders.

Authors:  Jacqueline E Muller; Liezl Koen; Dan J Stein
Journal:  Curr Psychiatry Rep       Date:  2005-08       Impact factor: 5.285

4.  QT variability index in patients with systemic sclerosis.

Authors:  Udi Nussinovitch; Shiri Rubin; Yair Levy; Merav Lidar; Avi Livneh
Journal:  Eur J Rheumatol       Date:  2018-10-01

5.  Panic disorder and incident coronary heart disease: a systematic review and meta-analysis protocol.

Authors:  Phillip J Tully; Gary A Wittert; Deborah A Turnbull; John F Beltrame; John D Horowitz; Suzanne Cosh; Harald Baumeister
Journal:  Syst Rev       Date:  2015-03-25

6.  Venlafaxine extended release (XR) in the treatment of panic disorder.

Authors:  Kevin Kjernisted; Diane McIntosh
Journal:  Ther Clin Risk Manag       Date:  2007-03       Impact factor: 2.423

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.